Organisation paid for research Program year 2024 Source: CMS Open Payments

Cardiovascular Research Center

Neither a doctor nor a teaching hospital

Research payments

$219,564

8 payments

Through program year 2024, Cardiovascular Research Center is reported as receiving $219,564 in research payments, across 8 payments.

By program year

5 rows
Year Kind Amount Payments
2024 Research $1,023 1
2023 Research $61,557 3
2022 Research $54,829 2
2021 Research $58,371 1
2020 Research $43,784 1

Breakdown

Who paid Research payments · program years 2020–2024
  1. Novartis Pharmaceuticals Corporation $214,064 6 payments
  2. AstraZeneca Pharmaceuticals LP $5,500 2 payments
Studies the money was for Research payments · program years 2020–2024
  1. Prospective Comparison of Arni With Arb Given Following Stabilization in Decompensated Hfpef (Paraglide-Hfpef) $173,084 4 payments
  2. Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (Victorion-2 Prevent) $40,980 2 payments
  3. Dapagliflozin in Acute Decompensated Heart Failure $5,500 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record